Nasdaq · Healthcare
Heartflow, Inc. (HTFL)
As-reported financials and recent SEC filings for Heartflow, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$176.0M
Net income
$-116.8M
Net margin
-66.3%
Diluted EPS
$-3.17
ROE
-38.8%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2025 | FY2025 |
|---|---|---|---|
| Revenue | $176.0M | $125.8M | $87.2M |
| Gross profit | $135.2M | $94.4M | $58.1M |
| Operating income | $-64.1M | $-61.2M | $-72.9M |
| Net income | $-116.8M | $-96.4M | $-95.7M |
| Diluted EPS | $-3.17 | $-2.57 | $-3.62 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-26
View on EDGAR →1442026-06-24
View on EDGAR →42026-06-18
View on EDGAR →42026-06-18
View on EDGAR →42026-06-18
View on EDGAR →42026-06-18
View on EDGAR →42026-06-18
View on EDGAR →42026-06-18
View on EDGAR →Largest Healthcare peers
Go deeper on HTFL
Search Heartflow, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.